Explore scientifically-backed products and resources to promote a healthy gut and overall well-being.
More than 50% of the world’s population are infected with H.pylori (4 billion people)
Helicobacter pylori (H. pylori) infections are treated with 2 or 3 antibiotics simultaneously,
often leading to incomplete eradication. This current treatment is inadequate.
It is a worldwide concern that antibiotics are gaining resistance.
Our first product to market HELIX treats the root cause and all the symptoms of H. pylori.
It can be used as a monotherapy or in conjunction with existing therapies.
HELIX aims to be an over-the-counter therapy, offering easier access to effective treatment,
and clinically tested to become a prescriptive therapy.
Leave us a message and we will aim to reply within 24 hours.